None
Quote | Roche Holding Div Rts (OTCMKTS:RHHVF)
Last: | $243.9799 |
---|---|
Change Percent: | 1.24% |
Open: | $237.09 |
Close: | $243.9799 |
High: | $243.9799 |
Low: | $237.09 |
Volume: | 5,153 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Roche Holding Div Rts (OTCMKTS:RHHVF)
2024-04-17 13:26:56 ET Summary Tempest Therapeutics, Inc. achieved positive results from phase 1b/2 study using TPST-1120 + Tecentriq + Avastin for the treatment of patients with 1st-line HCC; Significant improvements in both confirmed and unconfirmed responses. Updated results fr...
2024-04-17 10:24:12 ET Summary TG Therapeutics shares are down 60% from their 52-week high after rival MS therapy Ocrevus achieved non-inferiority as a subcutaneously injected therapy. Initial sales of TG Therapeutics' anti-CD20 MS treatment Briumvi were solid, generating $92 mill...
Message Board Posts | Roche Holding Div Rts (OTCMKTS:RHHVF)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RHHVF News Article - Roche introduces navify Algorithm Suite, a digital library of med | whytestocks | investorshangout | 04/11/2023 12:00:47 PM |
the future is here! | MasterofCoin15 | investorshub | 05/09/2015 9:38:18 PM |
Where in the money my good friend. | eddy2 | investorshub | 04/29/2015 12:44:25 PM |
Your not the first my friend. I bought | eddy2 | investorshub | 03/03/2015 3:57:24 PM |
Hello! Just wanted to be the very first | ChipandAchair | investorshub | 04/13/2014 9:27:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Div Rts Company Name:
RHHVF Stock Symbol:
OTCMKTS Market:
Friday, LumiraDx Limited (NASDAQ: LMDX) appointed joint administrators for two subsidiaries. The administrators signed a definitive ...
Poseida Therapeutics Inc (NASDAQ: PSTX) released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted a...
Poseida Therapeutics Inc (NASDAQ: PSTX) released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted a...